The role of vitamin D in the endocrinology controlling calcium homeostasis

JC Fleet - Molecular and cellular endocrinology, 2017 - Elsevier
Vitamin D and its' metabolites are a crucial part of the endocrine system that controls whole
body calcium homeostasis. The goal of this hormonal control is to regulate serum calcium …

[HTML][HTML] Current understanding of the molecular actions of vitamin D

G Jones, SA Strugnell, HF DeLUCA - Physiological reviews, 1998 - journals.physiology.org
Abstract Jones, Glenville, Stephen A. Strugnell, and Hector F. DeLuca. Current
Understanding of the Molecular Actions of Vitamin D. Physiol. Rev. 78: 1193–1231, 1998 …

Newly identified actions of the vitamin D endocrine system

MR Walters - Endocrine reviews, 1992 - academic.oup.com
Introduction V ITAMIN D is a seco-steroid in which the B-ring of the
cyclopentanoperhydrophenanthrene structure is cleaved. The vitamin is either obtained from …

1α,25‐Dihydroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action

H Shi, AW Norman, WH Okamura, A Sen… - The FASEB …, 2001 - Wiley Online Library
We reported recently that suppression of the renal lα, 25‐dihyroxyvitamin D3 (lα, 25‐(OH) 2‐
D3) production in aP2‐agouti transgenic mice by increasing dietary calcium decreases …

Vitamin D and its analogs as anticancer and anti-inflammatory agents

J Chen, Z Tang, AT Slominski, W Li… - European journal of …, 2020 - Elsevier
Vitamin D3 is the precursor of the steroid hormone calcitriol (1α, 25-dihydroxyvitamin D3), a
potent agonist of the transcription factor vitamin D receptor (VDR). Calcitriol has received …

A structural basis for the unique binding features of the human vitamin D-binding protein

C Verboven, A Rabijns, M De Maeyer… - Nature structural …, 2002 - nature.com
The human serum vitamin D-binding protein (DBP) has many physiologically important
functions, ranging from transporting vitamin D3 metabolites, binding and sequestering …

Clinical counterpoint: vitamin D: new actions, new analogs, new therapeutic potential

DD Bikle - Endocrine reviews, 1992 - academic.oup.com
Introduction AN EXCITING new era has developed in the vitamin D field with the discovery of
new target tissues, mechanisms of action, and selective analogs. As a clinical counterpoint …

[HTML][HTML] Demonstration that 1 beta, 25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three …

AW Norman, R Bouillon, MC Farach-Carson… - Journal of Biological …, 1993 - Elsevier
The steroid hormone 1 alpha, 25-dihydroxyvitamin D3 (1 alpha, 25-(OH) 2D3) generates
biological responses via both genomic and nongenomic mechanisms. This article reports …

Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1, 25-dihydroxyvitamin D3

RJ Skowronski, DM Peehl, D Feldman - Endocrinology, 1995 - academic.oup.com
Data from epidemiological studies has suggested that vitamin D deficiency may promote
prostate cancer, although the mechanism is not understood. We have previously …

Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1, 25-dihydroxyvitamin D3

MF Boehm, P Fitzgerald, A Zou, MG Elgort… - Chemistry & biology, 1999 - cell.com
Abstract Background: The secosteroid 1, 25-dihydroxyvitamin D 3 (1, 25 (OH) 2 D 3)
actsthrough the vitamin D receptor (VDR) to elicit many activities that make it a promising …